Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Chapter
  • Print publication year: 2011
  • Online publication date: May 2011

Chapter 8 - Pharmacogenetics of ovarian stimulation in the twenty-first century

Export citation
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Human Assisted Reproductive Technology
  • Online ISBN: 9780511734755
  • Book DOI: https://doi.org/10.1017/CBO9780511734755
Please enter your name
Please enter a valid email address
Who would you like to send this to *

CAPTCHA *

Skip to the audio challenge
×

References

2. de CastroF, MorónFJ, MontoroL, et al. Pharmacogenetics of controlled ovarian hyperstimulation. Pharmacogenomics 2005;6:629–37.
3. MaliziaBA, HackerMR, PenziasAS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med 2009;15:236–43.
4. DelvigneA, RozenbergS. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 2002;8:559–77.
5. GrebRR, BehreHM, SimoniM. Pharmacogenetics in ovarian stimulation – current concepts and future options. Reprod Biomed Online 2005;11:589–600.
6. OlivennesF, HowlesCM, BoriniA, et al. Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reprod Biomed Online 2009;18:195–204.
7. LoutradisD, VlismasA, DrakakisP, et al. Pharmacogenetics in ovarian stimulation – current concepts. Ann N Y Aca Sci 2008;1127:10–19.
8. GromollJ, SimoniM. Genetic complexity of FSH receptor function. Trends Endocrinol Metab 2005;16:368–73.
9. TrusheimMR, BerndtER, DouglasFL, et al. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat Rev Drug Discov 2007;6:287–93.
10. LussianaC, GuaniB, MariC, et al. Mutations and polymorphism of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv 2008;63:785–95.
11. OchsenkühnR, von Schönfeldt, SimoniM. FSH receptor polymorphisms and ovarian function. Med Reprod Gynecol Endocrinol 2009;11:265–70.
12. AchrekarSK, ModiDN, DesaiSK, et al. Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reprod Biomed Online 2009;18:509–15.
13. SimoniM, NieschlagE, GromollJ. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update 2002;8:413–21.
14. GrebRR, GrieshaberK, GromollJ, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab 2005;90:4866–72.
15. ZeleznikAJ, SchulerHM, ReichertLE Jr. Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 1981;109:356–62.
16. Perez MayorgaM, GromollJ, BehreHM, et al. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000;85:3365–9.
17. BehreHB, GrebRR, MempelA, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005;15:451–6.
18. DaelemansC, SmitsG, de MaertelaerV, et al. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 2004;89:6310–15.
19. OverbeekA, KuijperEA, HendriksML, et al. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod 2009;24:2007–13.
20. HomburgR. The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol 2003;1:109.
21. ImaniB, EijkemansMJ, te VeldeER, et al. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998;83:2361–5.
22. de CastroF, MoronFJ, MontoroL, et al. Re: polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2005;97:152–3.
23. SerdarE, SebastianS, TakayamaK, et al. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 2003;86:219–24.
24. GoldenbergRL, VaitukaitisJL, RossGT. Estrogen and follicle stimulation hormone interactions on follicle growth in rats. Endocrinology 1972;90:1492–8.
25. MenasceLP, WhiteGR, HarrisonCJ, et al. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993;17:263–5.
26. HillSM, FuquaSA, ChamnessGC, et al. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res 1989;49:145–8.
27. GeorgiouI, KonstantelliM, SyrrouM, et al. Oestrogen receptor gene polymorphisms and ovarian stimulation for in-vitro fertilization. Hum Reprod 1997;12:1430–3.
28. SundarrajanC, LiaoW, RoyAC. Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF. Mol Hum Reprod 1999;5:797–802.
29. de CastroF, MorónFJ, MontoroL, et al. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 2004;14:285–93.
30. de CastroF, RuizR, MontoroL, et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steri 2003;80:571–6.
31. SudoS, KudoM, WadaS, et al. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2002;8:893–9.
Cancel
Confirm
×